Matthew Boldy

Ask VT AI
View News Summary
  • Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
  • Israel conducts airstrikes in Syria, targeting military sites near Homs, Latakia, and Palmyra, amid ongoing U.S.-mediated talks to de-escalate the conflict.
  • Pret A Manger plans to trial meal deals in the UK to boost lunchtime sales and compete with supermarkets like Tesco amid rising food inflation.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
  • Israel conducts airstrikes in Syria, targeting military sites near Homs, Latakia, and Palmyra, amid ongoing U.S.-mediated talks to de-escalate the conflict.
  • Pret A Manger plans to trial meal deals in the UK to boost lunchtime sales and compete with supermarkets like Tesco amid rising food inflation.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Matthew Boldy